Patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes.

Children and adolescents with type 2 diabetes had greater reductions in HbA1c with an oral SGLT2 inhibitor compared with ...

Semaglutide is the active ingredient in Ozempic and Wegovy. Here's what you need to know, including which variation is FDA approved for weight loss.

Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.